US Pharma MarketingThe post EU region sees increase in multinational trial initiation in Q1 2026 appeared first on Clinical Trials Arena.
EU region sees increase in multinational trial initiation in Q1 2026
On top of its standard authorisation number, an additional 19 multinational trials were initiated in Q1 2026 in the EU. On top of its standard authorisation number, an additional 19 multinational trials were initiated in Q1 2026 in the EU. The EU has launched a number of schemes and incentives to attract more clinical trials to the region. Credit: FOTOGRIN / Shutterstock.com The European Commission (EC), the Heads of Medicines Agencies (HMA), and the European Medicines Agency (EMA) are seeing success in their aim to launch 500 extra multinational trials in the region by the end of 2030. In Q1…
On top of its standard authorisation number, an additional 19 multinational trials were initiated in Q1 2026 in the EU.
Source: Clinical Trials Arena